Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.
about
Combination therapy with an anti-IL-1β antibody and GAD65 DNA vaccine can reverse recent-onset diabetes in the RIP-GP mouse model.HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice.The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.Diabetes mellitus: new challenges and innovative therapies.IL-7 receptor α blockade, an off-switch for autoreactive T cells.Sibling method increases risk assessment estimates for type 1 diabetes.Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatmentImmunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the futureImmunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Dendritic cell therapy for Type 1 diabetes suppression.The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.Current practices and future outlook on the integration of biomarkers in the drug development process.
P2860
Q33646749-0E1AD95A-8122-471F-AA74-E7F7CC4667FEQ35660316-B4D81664-1E20-4565-B571-F68F2C260A47Q35665104-91165D71-74D4-4CA4-852C-4DB49D031544Q35976619-74BF6207-CB2B-4C03-98CE-E70369D52E73Q36117595-20ED5D70-9E6F-4083-A850-F8CA3C4B08E7Q36140521-B0D820CF-89E4-40C7-8807-7E52BAB13A62Q36373147-A5E30949-7C89-4274-9A55-140583536E94Q37263111-B1548F24-AB14-4006-A815-309C62CD71A4Q37364899-39375132-530E-41E9-AA3A-D6C3372265D4Q37883029-D7282AC0-C6DF-4C43-94FD-A9558F9FC6A3Q38059518-84C9675F-207D-48A2-845D-3D2AD615C264Q38963370-862832F4-1C5B-4C56-B46A-134CD59D74DDQ47626694-14631C68-AB14-4734-B788-BFDC362E6417
P2860
Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Immunotherapy for the preventi ...... he path from bench to bedside.
@en
Immunotherapy for the preventi ...... he path from bench to bedside.
@nl
type
label
Immunotherapy for the preventi ...... he path from bench to bedside.
@en
Immunotherapy for the preventi ...... he path from bench to bedside.
@nl
prefLabel
Immunotherapy for the preventi ...... he path from bench to bedside.
@en
Immunotherapy for the preventi ...... he path from bench to bedside.
@nl
P2860
P356
P1433
P1476
Immunotherapy for the preventi ...... he path from bench to bedside.
@en
P2093
Damien Bresson
Matthias von Herrath
P2860
P304
P356
10.2337/DC09-0373
P407
P577
2009-10-01T00:00:00Z